Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2925
0.245 %
$ 75.4 M
Market Cap
-0.95
P/E
ADAP - ACCOUNTS PAYABLE
Accounts Payable ADAP - Adaptimmune Therapeutics plc
8.69 M
LAST VALUE
35.23%
2 YEAR CAGR
6.46%
5 YEAR CAGR
15.93%
10 YEAR CAGR